The role of liquid biopsy as a catalyst for sustained progress in precision oncology – Perspective of the young committee of the international society of liquid biopsy
Erick Figueiredo Saldanha(Princess Margaret Cancer Centre), Carolina Reduzzi(Cornell University), Surbhi Singhal(International Society of Nephrology), Eleonora Nicolò(Cornell University), Diego de Miguel‐Pérez(Mount Sinai Health System), Angelo Dipasquale(IRCCS Humanitas Research Hospital), Mohamed A. Gouda(The University of Texas MD Anderson Cancer Center), Konstantinos Venetis(European Institute of Oncology), Ana Ortega-Franco(The Christie NHS Foundation Trust), George Adigbli(University of Oxford)
Cited by 11
Related Papers
ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer
|Nature Communications|2021|265
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
|Breast Cancer Research|2019|182
Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients
|Scientific Reports|2020|118
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
|Annals of Oncology|2023|103